المؤلفون: Lopes R, Abrantes JL, Kastenholz E

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::595d74357f0ecb77e267e830ba58778d

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Miranda MD; Laboratório de Morfologia e Morfogênese Viral, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro 21040-360, RJ, Brazil.; Laboratório de Estrutura e Regulação de Proteínas, Instituto de Bioquímica Médica, Programa de Biologia Estrutural, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, RJ, Brazil., Chaves OA; Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro 21040-360, RJ, Brazil.; Instituto Nacional para Ciência e Tecnologia sobre Inovação em Doenças de Populações Negligenciadas (INCT/IDPN), Centro de Desenvolvimento Tecnológico em Saúde (CDTS), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro 21040-360, RJ, Brazil., Rosa AS; Laboratório de Morfologia e Morfogênese Viral, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro 21040-360, RJ, Brazil., Azevedo AR; Centro Universitário UniLaSalle-RJ, Departamento de Engenharia de Produção, Niterói 24240-030, RJ, Brazil., Pinheiro LCDS; Departamento de Ciências, Faculdade de Formação de Professores, Universidade do Estado do Rio de Janeiro, São Gonçalo 24435-005, RJ, Brazil., Soares VC; Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro 21040-360, RJ, Brazil.; Programa de Imunologia e Inflamação, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, RJ, Brazil., Dias SSG; Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro 21040-360, RJ, Brazil., Abrantes JL; Laboratório de Estrutura e Regulação de Proteínas, Instituto de Bioquímica Médica, Programa de Biologia Estrutural, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, RJ, Brazil.; Instituto de Ciências Biomédicas (ICB), Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, RJ, Brazil.; Laboratório de Virologia Molecular, Instituto de Biologia, Programa de Pós-graduação em Ciências e Biotecnologia, Programa em Neurologia e Neurociências e Programa de Biotecnologia Marinha, Universidade Federal Fluminense, Niterói 24210-201, RJ, Brazil., Bernardino AMR; Instituto de Química, Departamento de Química Orgânica, Programa de Pós-graduação em Química, Universidade Federal Fluminense, Niterói 24020-007, RJ, Brazil., Paixão ICP; Laboratório de Virologia Molecular, Instituto de Biologia, Programa de Pós-graduação em Ciências e Biotecnologia, Programa em Neurologia e Neurociências e Programa de Biotecnologia Marinha, Universidade Federal Fluminense, Niterói 24210-201, RJ, Brazil., Souza TML; Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro 21040-360, RJ, Brazil.; Instituto Nacional para Ciência e Tecnologia sobre Inovação em Doenças de Populações Negligenciadas (INCT/IDPN), Centro de Desenvolvimento Tecnológico em Saúde (CDTS), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro 21040-360, RJ, Brazil., Fontes CFL; Laboratório de Estrutura e Regulação de Proteínas, Instituto de Bioquímica Médica, Programa de Biologia Estrutural, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, RJ, Brazil.

المصدر: International journal of molecular sciences [Int J Mol Sci] 2022 Jul 23; Vol. 23 (15). Date of Electronic Publication: 2022 Jul 23.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

مواضيع طبية MeSH: Herpes Simplex*/drug therapy , Herpesviridae Infections*/drug therapy , Herpesvirus 1, Human*/physiology, Acyclovir/pharmacology ; Animals ; Antiviral Agents/pharmacology ; Antiviral Agents/therapeutic use ; Chlorocebus aethiops ; Pyrazoles ; Pyridines/pharmacology ; Pyridines/therapeutic use ; Vero Cells ; Virus Replication

المؤلفون: Kuriyama SN; SESI Innovation Center for Occupational Health, Rio de Janeiro, Brazil.; SENAI Innovation Institute for Green Chemistry, Rio de Janeiro, Brazil., Farjun B; SESI Innovation Center for Occupational Health, Rio de Janeiro, Brazil.; SENAI Innovation Institute for Green Chemistry, Rio de Janeiro, Brazil., Henriques-Santos BM; SESI Innovation Center for Occupational Health, Rio de Janeiro, Brazil.; SENAI Innovation Institute for Green Chemistry, Rio de Janeiro, Brazil., Cabanelas A; SESI Innovation Center for Occupational Health, Rio de Janeiro, Brazil.; SENAI Innovation Institute for Green Chemistry, Rio de Janeiro, Brazil., Abrantes JL; Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil., Gesto J; Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil., Fidalgo-Neto AA; SENAI Innovation Institute for Green Chemistry, Rio de Janeiro, Brazil., Souza TML; SESI Innovation Center for Occupational Health, Rio de Janeiro, Brazil.; Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.; National Institute for Science and Technology for Innovation on Diseases of Neglected Populations (INCT/IDPN), Center for Technological Development in Health (CDTS), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, Brazil.

المصدر: Frontiers in medicine [Front Med (Lausanne)] 2022 Apr 29; Vol. 9, pp. 862284. Date of Electronic Publication: 2022 Apr 29 (Print Publication: 2022).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101648047 Publication Model: eCollection Cited Medium: Print ISSN: 2296-858X (Print) Linking ISSN: 2296858X NLM ISO Abbreviation: Front Med (Lausanne) Subsets: PubMed not MEDLINE

المؤلفون: Temerozo JR; Laboratory on Thymus Research, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil.; National Institute for Science and Technology on Neuroimmunomodulation (INCT/NIM), Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil.; Laboratory of Immunopharmacology, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil.; Center for Technological Development in Health (CDTS), National Institute for Science and Technology on Innovation on Disease Of Neglected Poppulations (INCT/IDPN), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil., Fintelman-Rodrigues N; Laboratory of Immunopharmacology, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil.; Center for Technological Development in Health (CDTS), National Institute for Science and Technology on Innovation on Disease Of Neglected Poppulations (INCT/IDPN), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil., Dos Santos MC; Laboratory of Immunopharmacology, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil., Hottz ED; Laboratory of Immunopharmacology, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil.; Laboratory of Immunothrombosis, Department of Biochemistry, Federal University of Juiz de Fora (UFJF), Juiz de Fora, Minas Gerais, Brazil., Sacramento CQ; Laboratory of Immunopharmacology, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil.; Center for Technological Development in Health (CDTS), National Institute for Science and Technology on Innovation on Disease Of Neglected Poppulations (INCT/IDPN), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil., de Paula Dias da Silva A; Laboratory of Immunopharmacology, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil.; Center for Technological Development in Health (CDTS), National Institute for Science and Technology on Innovation on Disease Of Neglected Poppulations (INCT/IDPN), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil., Mandacaru SC; Center for Technological Development in Health (CDTS), National Institute for Science and Technology on Innovation on Disease Of Neglected Poppulations (INCT/IDPN), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil.; Laboratory of Toxinology, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil., Dos Santos Moraes EC; Laboratory of Immunopharmacology, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil.; Laboratory of Toxinology, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil., Trugilho MRO; Center for Technological Development in Health (CDTS), National Institute for Science and Technology on Innovation on Disease Of Neglected Poppulations (INCT/IDPN), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil.; Laboratory of Toxinology, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil., Gesto JSM; Center for Technological Development in Health (CDTS), National Institute for Science and Technology on Innovation on Disease Of Neglected Poppulations (INCT/IDPN), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil., Ferreira MA; Center for Technological Development in Health (CDTS), National Institute for Science and Technology on Innovation on Disease Of Neglected Poppulations (INCT/IDPN), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil., Saraiva FB; Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil., Palhinha L; Laboratory of Immunopharmacology, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil., Martins-Gonçalves R; Laboratory of Immunopharmacology, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil., Azevedo-Quintanilha IG; Laboratory of Immunopharmacology, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil., Abrantes JL; Instituto de Ciências Biomédicas, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil., Righy C; Paulo Niemeyer State Brain Institute (IECPN), Rio de Janeiro, RJ, Brazil.; Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil., Kurtz P; Paulo Niemeyer State Brain Institute (IECPN), Rio de Janeiro, RJ, Brazil.; D'Or Institute for Research and Education, Rio de Janeiro, RJ, Brazil., Jiang H; MGI Tech Co. Ltd, Building No.11, Beishan Industrial Zone, Yantian District, Shenzhen, 518083, China., Tan H; MGI Tech Co. Ltd, Building No.11, Beishan Industrial Zone, Yantian District, Shenzhen, 518083, China., Morel C; Center for Technological Development in Health (CDTS), National Institute for Science and Technology on Innovation on Disease Of Neglected Poppulations (INCT/IDPN), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil., Bou-Habib DC; Laboratory on Thymus Research, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil.; National Institute for Science and Technology on Neuroimmunomodulation (INCT/NIM), Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil., Bozza FA; Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil.; D'Or Institute for Research and Education, Rio de Janeiro, RJ, Brazil., Bozza PT; Laboratory of Immunopharmacology, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil., Souza TML; Laboratory of Immunopharmacology, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil. souzatml@gmail.com.; Center for Technological Development in Health (CDTS), National Institute for Science and Technology on Innovation on Disease Of Neglected Poppulations (INCT/IDPN), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil. souzatml@gmail.com.

المصدر: Microbiome [Microbiome] 2022 Apr 22; Vol. 10 (1), pp. 65. Date of Electronic Publication: 2022 Apr 22.

نوع المنشور: Journal Article; Video-Audio Media; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101615147 Publication Model: Electronic Cited Medium: Internet ISSN: 2049-2618 (Electronic) Linking ISSN: 20492618 NLM ISO Abbreviation: Microbiome Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19* , Endogenous Retroviruses*/genetics, Critical Illness ; Humans ; Inflammation ; Respiratory System ; SARS-CoV-2

المؤلفون: Cunha AC; Departamento de Química Orgânica, Instituto de Química, Outeiro de São João Batista, Universidade Federal Fluminense, Niterói, RJ, 24020-141, Brazil., Ferreira VF; Departamento de Tecnologia Farmacêutica, Faculdade de Farmácia, Universidade Federal Fluminense, Rua Dr. Mário Vianna 523, Niterói, RJ, 24241-002, Brazil., Vaz MGF; Departamento de Química Inorgânica, Instituto de Química, Outeiro de São João Batista, Universidade Federal Fluminense, Niterói, RJ, 24020-141, Brazil., Cassaro RAA; Departamento de Química Inorgânica, Instituto de Química, Universidade Federal Do Rio de Janeiro, Rio de Janeiro, RJ, 21941-972, Brazil., Resende JALC; Laboratório de difração de Raios X, Programa de Pós-Graduação Em Química, Universidade Federal Fluminense, Niterói, RJ, 24020-141, Brazil.; Instituto de Ciências Exatas E da Terra, Universidade Federal do Mato Grosso, Barra do Garças, MT, 78698-000, Brazil., Sacramento CQ; Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz, FIOCRUZ, Rio de Janeiro, Brazil., Costa J; Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz, FIOCRUZ, Rio de Janeiro, Brazil., Abrantes JL; Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz, FIOCRUZ, Rio de Janeiro, Brazil., Souza TML; Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz, FIOCRUZ, Rio de Janeiro, Brazil.; National Institute for Science and Technology On Innovation On Diseases of Neglected Populations (INCT/IDPN), Center for Technological Development in Health (CDTS), Fiocruz, Rio de Janeiro, RJ, Brazil., Jordão AK; Departamento de Farmácia, Universidade Federal do Rio Grande do Norte, Natal, RN, 59012-570, Brazil. akjordao@ccs.ufrn.br.

المصدر: Molecular diversity [Mol Divers] 2021 Nov; Vol. 25 (4), pp. 2035-2043. Date of Electronic Publication: 2020 May 06.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: ESCOM Science Publishers Country of Publication: Netherlands NLM ID: 9516534 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-501X (Electronic) Linking ISSN: 13811991 NLM ISO Abbreviation: Mol Divers

مواضيع طبية MeSH: Antiviral Agents*/pharmacology , Antiviral Agents*/chemistry , Herpesvirus 1, Human*/drug effects , Triazoles*/chemistry , Triazoles*/pharmacology , Nitrogen Oxides*/chemistry , Nitrogen Oxides*/pharmacology, Chlorocebus aethiops ; Vero Cells ; Animals ; Structure-Activity Relationship ; Acyclovir/pharmacology ; Acyclovir/chemistry ; Virus Replication/drug effects ; Cyclic N-Oxides/chemistry ; Cyclic N-Oxides/pharmacology

المؤلفون: Forezi LDSM; Laboratório LNHC, Departamento de Química Orgânica, Instituto de Química, Universidade Federal Fluminense, Campus Valonguinho, 24020-150, Niterói-RJ, Brazil., Ribeiro MMJ; Laboratório de Modelagem Molecular e QSAR (ModMolQSAR), Faculdade de Farmácia, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil., Marttorelli A; Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, RJ, Brazil; National Institute for Science and Technology on Innovation on Neglected Diseases (INCT/IDN), Center for Technological Development in Health (CDTS), Fiocruz, Rio de Janeiro, RJ, Brazil., Abrantes JL; Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, RJ, Brazil; National Institute for Science and Technology on Innovation on Neglected Diseases (INCT/IDN), Center for Technological Development in Health (CDTS), Fiocruz, Rio de Janeiro, RJ, Brazil., Rodrigues CR; Laboratório de Modelagem Molecular e QSAR (ModMolQSAR), Faculdade de Farmácia, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil., Castro HC; Laboratório de Antibióticos, Bioquímica, Ensino e Modelagem Molecular (LABiEMol), Instituto de Biologia, Universidade Federal Fluminense, Niterói, RJ, Brazil., Souza TML; Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, RJ, Brazil; National Institute for Science and Technology on Innovation on Neglected Diseases (INCT/IDN), Center for Technological Development in Health (CDTS), Fiocruz, Rio de Janeiro, RJ, Brazil., Boechat FDCS; Laboratório LNHC, Departamento de Química Orgânica, Instituto de Química, Universidade Federal Fluminense, Campus Valonguinho, 24020-150, Niterói-RJ, Brazil., de Souza AMT; Laboratório de Modelagem Molecular e QSAR (ModMolQSAR), Faculdade de Farmácia, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil. Electronic address: amtsouza@pharma.ufrj.br., de Souza MCBV; Laboratório LNHC, Departamento de Química Orgânica, Instituto de Química, Universidade Federal Fluminense, Campus Valonguinho, 24020-150, Niterói-RJ, Brazil. Electronic address: mceciliabvs@gmail.com.

المصدر: European journal of medicinal chemistry [Eur J Med Chem] 2020 May 15; Vol. 194, pp. 112255. Date of Electronic Publication: 2020 Mar 20.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 0420510 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1768-3254 (Electronic) Linking ISSN: 02235234 NLM ISO Abbreviation: Eur J Med Chem Subsets: MEDLINE

مواضيع طبية MeSH: 4-Quinolones/*pharmacology , Anti-HIV Agents/*pharmacology , HIV Reverse Transcriptase/*antagonists & inhibitors , HIV-1/*drug effects , Reverse Transcriptase Inhibitors/*pharmacology , Ribonucleosides/*pharmacology, 4-Quinolones/chemical synthesis ; 4-Quinolones/chemistry ; Anti-HIV Agents/chemical synthesis ; Anti-HIV Agents/chemistry ; Dose-Response Relationship, Drug ; Drug Design ; HIV Reverse Transcriptase/metabolism ; HIV-1/metabolism ; Humans ; Microbial Sensitivity Tests ; Models, Molecular ; Molecular Structure ; Reverse Transcriptase Inhibitors/chemical synthesis ; Reverse Transcriptase Inhibitors/chemistry ; Ribonucleosides/chemical synthesis ; Ribonucleosides/chemistry ; Structure-Activity Relationship

المؤلفون: Sacramento CQ; Laboratorio de Vírus Respiratorios, Instituto Oswaldo Cruz, Fundacao Oswaldo Cruz, Rio de Janeiro, Rio de Janeiro, Brazil.; Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Rio de Janeiro, Brazil.; National Institute for Science and Technology on Innovation on Diseases of Neglected Populations (INCT/IDNP), Center for Technological Development in Health (CDTS), Oswaldo Cruz Foundation, Rio de Janeiro, Rio de Janeiro, Brazil., Jordão AK; Laboratório de Síntese Orgânica, Programa de pós-Graduação em Química, Departamento de Química Orgânica, Instituto de Química, Universidade Federal Fluminense, Niterói, Rio de Janeiro, Brazil.; Unidade Universitária de Farmácia, Fundação Centro Universitário Estadual da Zona Oeste, Rio de Janeiro, Rio de Janeiro, Brazil., Abrantes JL; Instituto de Ciencias Biomedicas, Centro de Ciencias da Saude, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Rio de Janeiro, Brazil., Alves CM; Laboratorio de Vírus Respiratorios, Instituto Oswaldo Cruz, Fundacao Oswaldo Cruz, Rio de Janeiro, Rio de Janeiro, Brazil., Marttorelli A; Laboratorio de Vírus Respiratorios, Instituto Oswaldo Cruz, Fundacao Oswaldo Cruz, Rio de Janeiro, Rio de Janeiro, Brazil.; Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Rio de Janeiro, Brazil.; National Institute for Science and Technology on Innovation on Diseases of Neglected Populations (INCT/IDNP), Center for Technological Development in Health (CDTS), Oswaldo Cruz Foundation, Rio de Janeiro, Rio de Janeiro, Brazil., Fintelman-Rodrigues N; Laboratorio de Vírus Respiratorios, Instituto Oswaldo Cruz, Fundacao Oswaldo Cruz, Rio de Janeiro, Rio de Janeiro, Brazil.; Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Rio de Janeiro, Brazil.; National Institute for Science and Technology on Innovation on Diseases of Neglected Populations (INCT/IDNP), Center for Technological Development in Health (CDTS), Oswaldo Cruz Foundation, Rio de Janeiro, Rio de Janeiro, Brazil., de Freitas CS; Laboratorio de Vírus Respiratorios, Instituto Oswaldo Cruz, Fundacao Oswaldo Cruz, Rio de Janeiro, Rio de Janeiro, Brazil.; Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Rio de Janeiro, Brazil.; National Institute for Science and Technology on Innovation on Diseases of Neglected Populations (INCT/IDNP), Center for Technological Development in Health (CDTS), Oswaldo Cruz Foundation, Rio de Janeiro, Rio de Janeiro, Brazil., de Melo GR; Laboratorio de Vírus Respiratorios, Instituto Oswaldo Cruz, Fundacao Oswaldo Cruz, Rio de Janeiro, Rio de Janeiro, Brazil.; Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Rio de Janeiro, Brazil.; National Institute for Science and Technology on Innovation on Diseases of Neglected Populations (INCT/IDNP), Center for Technological Development in Health (CDTS), Oswaldo Cruz Foundation, Rio de Janeiro, Rio de Janeiro, Brazil., Cunha AC; Laboratório de Síntese Orgânica, Programa de pós-Graduação em Química, Departamento de Química Orgânica, Instituto de Química, Universidade Federal Fluminense, Niterói, Rio de Janeiro, Brazil., Ferreira VF; Laboratório de Síntese Orgânica, Programa de pós-Graduação em Química, Departamento de Química Orgânica, Instituto de Química, Universidade Federal Fluminense, Niterói, Rio de Janeiro, Brazil., Souza TML; Laboratorio de Vírus Respiratorios, Instituto Oswaldo Cruz, Fundacao Oswaldo Cruz, Rio de Janeiro, Rio de Janeiro, Brazil.; Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Rio de Janeiro, Brazil.; National Institute for Science and Technology on Innovation on Diseases of Neglected Populations (INCT/IDNP), Center for Technological Development in Health (CDTS), Oswaldo Cruz Foundation, Rio de Janeiro, Rio de Janeiro, Brazil.

المصدر: Current topics in medicinal chemistry [Curr Top Med Chem] 2020; Vol. 20 (2), pp. 132-139.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Bentham Science Publishers Country of Publication: United Arab Emirates NLM ID: 101119673 Publication Model: Print Cited Medium: Internet ISSN: 1873-4294 (Electronic) Linking ISSN: 15680266 NLM ISO Abbreviation: Curr Top Med Chem Subsets: MEDLINE

مواضيع طبية MeSH: Antiviral Agents/*pharmacology , Enzyme Inhibitors/*pharmacology , Influenza A virus/*drug effects , Influenza B virus/*drug effects , Neuraminidase/*antagonists & inhibitors , Piperidines/*pharmacology , Thiazoles/*pharmacology , Triazoles/*pharmacology, Antiviral Agents/chemical synthesis ; Antiviral Agents/chemistry ; Cell Survival/drug effects ; Dose-Response Relationship, Drug ; Enzyme Inhibitors/chemical synthesis ; Enzyme Inhibitors/chemistry ; Influenza A virus/enzymology ; Influenza B virus/enzymology ; Microbial Sensitivity Tests ; Molecular Docking Simulation ; Molecular Structure ; Neuraminidase/metabolism ; Piperidines/chemical synthesis ; Piperidines/chemistry ; Structure-Activity Relationship ; Thiazoles/chemical synthesis ; Thiazoles/chemistry ; Triazoles/chemical synthesis ; Triazoles/chemistry

المؤلفون: Seabra C; University of Coimbra, Faculty of Arts & Humanities, CEGOT - Geography and Spatial Planning Research Centre, NOVASBE - Nova School of Business and Economics, CI&DETS - Centre for the Study of Education, Technologies and Health, CISeD - Research Center in Digital Services, Portugal., Reis P; Polytechnic Institute of Viseu, CI&DETS - Centre for the Study of Education, Technologies and Health, CISeD - Research Center in Digital Services, Portugal., Abrantes JL; Polytechnic Institute of Viseu, CI&DETS - Centre for the Study of Education, Technologies and Health, CISeD - Research Center in Digital Services, Portugal.

المصدر: Annals of tourism research [Ann Tour Res] 2020 Jan; Vol. 80, pp. 102811. Date of Electronic Publication: 2019 Oct 31.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101765681 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7722 (Electronic) Linking ISSN: 01607383 NLM ISO Abbreviation: Ann Tour Res Subsets: PubMed not MEDLINE